Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-07-02FDA Approved: DOCETAXEL — Original Application (Mylan Institutional LLC)
FDA approved an original application for a generic docetaxel product (docetaxel anhydrous) from Mylan Institutional LLC. The generic is an i…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies [NA]
A completed clinical trial evaluating a powered vascular stapler in video-assisted thoracoscopic lobectomies for non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety. [NA]
Completed clinical trial evaluating whether Qigong can alleviate dyspnea, fatigue, and anxiety in patients with non-small cell lung cancer o…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC [Phase 3]
Phase 3 trial comparing PF-06439535 plus paclitaxel and carboplatin against bevacizumab plus paclitaxel and carboplatin in advanced non-squa…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of ISIS EIF4E Rx in combination with carboplatin and paclitaxel in non-small cell lung cancer has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 study of abemaciclib (LY2835219) in participants with stage IV squamous non-small cell lung cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants [Phase 2]
Phase 2 trial update for emibetuzumab in non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel [NA]
This document provides an update on a Phase I clinical trial evaluating the combination of Anlotinib with pemetrexed or with docetaxel in pa…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients [Phase 2]
Phase 2 trial testing AZD6244 (selumetinib) in combination with docetaxel versus docetaxel alone in KRAS-mutant non-small cell lung cancer h…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Combination of Metformin With Gefitinib to Treat NSCLC [Phase 2]
Phase 2 trial evaluating metformin in combination with gefitinib for non-small cell lung cancer has completed. The update notes the study st…
-
CLINICAL_TRIALS trial_result · 2018-06-18Clinical Trial Update: Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery [Phase 1]
A Phase 1 trial evaluating a new anti-cancer vaccine in patients with Non-small cell lung cancer after tumor removal by surgery was terminat…
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer [Phase 2]
Phase II study evaluating carboplatin and pemetrexed with or without OGX-427 in untreated stage IV non-squamous non-small cell lung cancer h…
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 2]
Phase 2 trial comparing intermittent and maintenance icotinib in combination with pemetrexed/carboplatin versus icotinib alone in EGFR-mutan…
-
CLINICAL_TRIALS research · 2018-06-07Clinical Trial Update: A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC
A prospective study at Shanghai Chest Hospital is evaluating how consistently next-generation sequencing panels perform using malignant pleu…
-
FDA approval · 2018-06-05FDA Approved: ALECENSA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for ALECENSA (alectinib hydrochloride) filed by Genentech, Inc., authorizing changes to its labe…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before [Phase 2]
Phase 2 study evaluating Cixutumumab (IMC-A12) with or without standard chemotherapies in patients with treatment-naive non-small cell lung …
-
CLINICAL_TRIALS research · 2018-06-01Clinical Trial Update: Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation [Phase 2]
Clinical trial update on dabrafenib and trametinib in non-small cell lung cancer harboring the BRAF V600E mutation (Phase 2).
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Personalized DC Vaccine for Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating a personalized dendritic cell vaccine for non-small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC [Phase 1]
Phase 1 clinical trial update evaluating sequential anti-CTLA-4 antibody followed by anti-PD-1 antibody in recurrent or metastatic non-small…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer [Phase 1]
A Phase I trial of hypofractionated stereotactic boost radiotherapy for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations [Phase 1, Phase 2]
Pfizer studied lorlatinib (PF-06463922), an ALK/ROS1 inhibitor, in patients with advanced non-small cell lung cancer harboring ALK or ROS1 a…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: The Jules Bordet Institute Molecular Profiling Program Feasibility Trial [NA]
Feasibility trial update from the Jules Bordet Institute molecular profiling program; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating circulating T cells and tumor-infiltrating lymphocytes during/after pre-surgery chemotherapy in non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
This clinical trial update reports on the effectiveness and safety of surgical interventions in elderly patients with non-small cell lung ca…
-
CLINICAL_TRIALS research · 2018-05-21Clinical Trial Update: A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
Clinical study at Tang-Du Hospital that investigates prognoses for patients with N2 non-small cell lung cancer; the study status is complete…